Orringer, D. A., Sagher, O., Heth, J., Hervey-Jumper, S. L., Mammoser, A., Junck, L., Leung, D., Umemura, Y., Lawrence, T., Kim, M., Wahl, D., McKeever, P., Camelo-Piragua, S., Lieberman, A., Venneti, S., Verbal, K., Sagher, K., Dunn, P., Zamler, D., Yadav, V., Comba, A., Altshuler, D., Zhao, L., Muraszko, K. M., Castro, M. G., & Lowenstein, P. (n.d.). first in Human Phase I Trial of Dual Vector (HSV1-TK, Flt3L) Immunotherapy For The Treatment of Newly Diagnosed High-Grade Glioma: Initial Results. Neurosurgery, 66, . http://access.bl.uk/ark:/81055/vdc_100183596544.0x00003d